In a recent report by the Health Products Regulatory Authority (HPRA), it has been disclosed that Ireland is grappling with a shortage of antibiotic tablets commonly used for treating ear infections and sinusitis. The affected medication, a generic form of Augmentin, is anticipated to remain unavailable until next month, intensifying concerns about dwindling stock levels.
Patients currently using Augmentin are advised to consult with their doctors to explore alternative medications. The European Union, including Ireland, is witnessing shortages across various medicines, heightening the need for proactive measures.
Meanwhile, the Pharmacy Union has been advocating for pharmacists to be granted the authority to prescribe substitute medications when faced with stock unavailability, eliminating the necessity for patients to revisit their doctors. The government has responded by temporarily authorizing pharmacists to dispense select medicines without requiring regular doctor supervision, extending prescription validity for the next 12 months. The union awaits a favorable decision in its ongoing efforts to empower pharmacists during these challenging times.